Relation between aberrant α-catenin expression and loss of E-cadherin function in prostate cancer

International Journal of Cancer

Volumn 74, Issue 4, 1997, Pages 374-377

  Umbas, Rainy ^a,c,d   Isaacs, William B ^b   Bringuier, Pierre Paul ^a   Xue, Yong ^a   Debrune, Frans M J ^a   Schalken, Jack A ^a,c,d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; UVOMORULIN;

ARTICLE; CANCER GRADING; CANCER GROWTH; CELL ADHESION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER;

ALPHA CATENIN; CADHERINS; CYTOSKELETAL PROTEINS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM STAGING; PROGNOSIS; PROSTATIC NEOPLASMS; SURVIVAL RATE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030864719     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970822)74:4<374::AID-IJC2>3.0.CO;2-S     Document Type: Article

References (20)

1. ADOLFSSON, J., RÖNSTRÖM, L., CARSTENSEN, J., LÖWHAOEN, T. and HEDLUND, P.O., The natural course of low grade, non-metastatic prostate carcinoma. Brit. J. Urol., 65, 611-614 (1990).
2. BIRCHMEIER, W. and BEHRENS, J., Cadherin expression in carcinomas: role in the formation of junctions and the prevention of invasiveness. Biochem. biophys. Acta 1198, 11-26 (1994).
3. BOSTWICK, D.G. and 12 OTHERS, Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology, 41, 403-411 (1993).
4. BUSSEMAKERS, M.J.G., VAN MOORSELAAR, R.J.A., GlROLDI, L.A., ICHIKAWA, T., ISAACS, J.T., TAKEICHI, M., DEBRUYNE, F.M.J. and SCHALKEN, J.A., Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res., 52, 5104-5109 (1992).
5. FRIXEN, U.H., BEHRENS, J., SACHS, M., EBERLE, G., VOSS, B., WARSA, A., LÖCHNER, D. and BIRCHMEIER, W., E-cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol., 113, 173-185 (1991).
6. GEORGE, N.J.R., Natural history of localised prostatic cancer managed by conservative therapy alone. Lancet, i, 494-497 (1988).
7. GLEASON, D.F., Histologic grading and clinical staging of prostatic carcinoma. In: M Tannenbaum (ed.), Urologic Pathology: The Prostate, pp. 171-197. Lea & Fehiger, Philadelphia (1977).
8. GRAYHACK, J.T. and ASSIMOS, D.G., Prognostic significance of tumor grade and stage in the patient with carcinoma of the prostate. Prostate, 4, 13-31 (1983).
9. HIRANO, S., KIMOTO, N., SHIMOYAMA, Y., HIROHASHI, S. and TAKEICHI, M., Identification of a neural alpha-catenin as a key regulator of cadherin function and multicellular organization. Cell, 70, 293-301 (1992).
10. JOHANSSON, J.-E., ADAMI, H.-O., ANDERSSON, S.-O., BERGSTRÖM, R., KRUSEMO, B. and KRAAZ, W., Natural history of localized prostatic cancer: a population-based study in 223 untreated patients. Lancet, i, 799-803 (1989).
11. KADOWAKI, T., SHIOZAKI, H., INOUE, M., TAMURA, S., OKA, H., DOKI, Y., IIHARA, K., MATSUI, S., IWAZAWA, T., NAGAFUCHI, A., TSUKITA, S. and MORI, T., E-cadherin and α-catenin expression in human esophageal cancer. Cancer Res., 54, 291-296 (1994).
12. MORTON, R.A., EWING, C.M., NAGAFUCHI, A., TSUKITA, S. and ISAACS, W.B., Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res., 53, 3585-3590 (1993).
13. MORTON, R.A., STLINER, M.S. and WALSH, P.C., Cancer control following anatomical radical prostateclomy: an interim report. J. Urol., 145, 1197- 1200 (1991).
14. OKA, H., SHIOZAKI, H., KUBAYASHI, K., TAHAKA, H., TAMURA, S., MIYATA, M., DOKI, Y., IIHARA, K., MATSUYOSHI, N., HIRANO, S., TAKEICHI, M. and MORI, T., Immunohistochcmical evaluation of E-cadherin molecule expression in human gastric cancer. Virchows Arch. A. Pathol. Anat., 421, 149-156 (1992).
15. SCHIPPER, J.H., FRIXEN, U.H., BEHRENS, J., UNGER, A., JAHNKE, K. and BIRCHMEIER, W., E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with minor differentiation and lymph node metastasis. Cancer Res., 51, 6328-6337 (1991).
16. SHIMOYAMA, Y. and HIROHASHI, S., Expression of E- and P-cadherin in gastric carcinoma. Cancer Res., 51, 2185-2192 (1991).
17. SHIMOYAMA, Y., NAGAFUCHI, A., FUJITA, S., GOTOH, M., TAKEICHI, M., TSUKITA, S. and HIROHASHI, S., Cadherin dysfunction in a human cell line: possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness. Cancer Res., 52, 5770-5774 (1992).
18. TAKEICHI, M., The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development, 102, 639-655 (1988).
19. UMBAS, R., ISAACS, W.B., BRINGUIER, P.P., SCHAAFSMA, H.E., KARTHAUS, H.F.M., OOSTERHOF, G.O.N., DEBRUYNE, F.M.J. and SCHALKEN, J.A., Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res., 54, 3929-3933 (1994).
20. UMBAS, R., SCHALKEN, J.A., AALDERS, T.W., CARTER, B.S., KARTHAUS, H.F.M., SCHAAFSMA, H.E., DEBRUYNE, F.M.J. and ISAACS, W.B., Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res., 52, 5104-5109 (1992).